The effect of gonadotropin-releasing hormone agonist on thyroid- stimulating hormone and prolactin secretion in adult premenopausal women

S. J. Chantilis, C. Barnett-Hamm, W. E. Byrd, B. R. Carr

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objective: To investigate the effects of chronic administration of GnRH agonists (GnRH-a) on pituitary TSH and PRL secretion in adult women. Design: Prospective case-controlled study. Setting: Academic division of Reproductive Endocrinology, Department of Obstetrics and Gynecology. Patients: Ten ovulatory women and 10 women treated with monthly depot injections of leuprolide acetate (3.75 mg) were studied. Interventions: All subjects underwent pituitary stimulation with human thyrotropin-releasing hormone (TRH), 500 μg IV. Main Outcome Measures: Basal and post-TRH-stimulated serum levels of TSH and PRL at 15, 30, 45, 60, 90, 120, and 180 minutes were compared among the two groups. Also, basal of T4, triiodothyronine, and triiodothyronine resin uptake studies were obtained and compared among the GnRH-a-treated and control groups. Results: No statistically significant difference between baseline or TRH-stimulated serum TSH and PRL could be detected between control and GnRH-a-treated groups of women. Furthermore, these groups were similar with respect to routine thyroid function assays. Conclusion: Gonadotropin-releasing hormone agonist does not significantly affect baseline or TRH-stimulated TSH and PRL levels nor basal serum T4 and triiodothyronine levels or triiodothyronine resin uptake in adult women.

Original languageEnglish (US)
Pages (from-to)698-702
Number of pages5
JournalFertility and Sterility
Volume64
Issue number4
StatePublished - 1995

Fingerprint

Thyrotropin
Gonadotropin-Releasing Hormone
Thyrotropin-Releasing Hormone
Prolactin
Triiodothyronine
Serum
Leuprolide
Hospital Obstetrics and Gynecology Department
Endocrinology
Gynecology
Thyroid Gland
Outcome Assessment (Health Care)
Control Groups
Injections

Keywords

  • Gonadotropin-releasing hormone agonist
  • pituitary
  • prolactin
  • thyroid-stimulating hormone

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

The effect of gonadotropin-releasing hormone agonist on thyroid- stimulating hormone and prolactin secretion in adult premenopausal women. / Chantilis, S. J.; Barnett-Hamm, C.; Byrd, W. E.; Carr, B. R.

In: Fertility and Sterility, Vol. 64, No. 4, 1995, p. 698-702.

Research output: Contribution to journalArticle

@article{0ef59d2cf2234aa5b2b8fcea51c0f368,
title = "The effect of gonadotropin-releasing hormone agonist on thyroid- stimulating hormone and prolactin secretion in adult premenopausal women",
abstract = "Objective: To investigate the effects of chronic administration of GnRH agonists (GnRH-a) on pituitary TSH and PRL secretion in adult women. Design: Prospective case-controlled study. Setting: Academic division of Reproductive Endocrinology, Department of Obstetrics and Gynecology. Patients: Ten ovulatory women and 10 women treated with monthly depot injections of leuprolide acetate (3.75 mg) were studied. Interventions: All subjects underwent pituitary stimulation with human thyrotropin-releasing hormone (TRH), 500 μg IV. Main Outcome Measures: Basal and post-TRH-stimulated serum levels of TSH and PRL at 15, 30, 45, 60, 90, 120, and 180 minutes were compared among the two groups. Also, basal of T4, triiodothyronine, and triiodothyronine resin uptake studies were obtained and compared among the GnRH-a-treated and control groups. Results: No statistically significant difference between baseline or TRH-stimulated serum TSH and PRL could be detected between control and GnRH-a-treated groups of women. Furthermore, these groups were similar with respect to routine thyroid function assays. Conclusion: Gonadotropin-releasing hormone agonist does not significantly affect baseline or TRH-stimulated TSH and PRL levels nor basal serum T4 and triiodothyronine levels or triiodothyronine resin uptake in adult women.",
keywords = "Gonadotropin-releasing hormone agonist, pituitary, prolactin, thyroid-stimulating hormone",
author = "Chantilis, {S. J.} and C. Barnett-Hamm and Byrd, {W. E.} and Carr, {B. R.}",
year = "1995",
language = "English (US)",
volume = "64",
pages = "698--702",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - The effect of gonadotropin-releasing hormone agonist on thyroid- stimulating hormone and prolactin secretion in adult premenopausal women

AU - Chantilis, S. J.

AU - Barnett-Hamm, C.

AU - Byrd, W. E.

AU - Carr, B. R.

PY - 1995

Y1 - 1995

N2 - Objective: To investigate the effects of chronic administration of GnRH agonists (GnRH-a) on pituitary TSH and PRL secretion in adult women. Design: Prospective case-controlled study. Setting: Academic division of Reproductive Endocrinology, Department of Obstetrics and Gynecology. Patients: Ten ovulatory women and 10 women treated with monthly depot injections of leuprolide acetate (3.75 mg) were studied. Interventions: All subjects underwent pituitary stimulation with human thyrotropin-releasing hormone (TRH), 500 μg IV. Main Outcome Measures: Basal and post-TRH-stimulated serum levels of TSH and PRL at 15, 30, 45, 60, 90, 120, and 180 minutes were compared among the two groups. Also, basal of T4, triiodothyronine, and triiodothyronine resin uptake studies were obtained and compared among the GnRH-a-treated and control groups. Results: No statistically significant difference between baseline or TRH-stimulated serum TSH and PRL could be detected between control and GnRH-a-treated groups of women. Furthermore, these groups were similar with respect to routine thyroid function assays. Conclusion: Gonadotropin-releasing hormone agonist does not significantly affect baseline or TRH-stimulated TSH and PRL levels nor basal serum T4 and triiodothyronine levels or triiodothyronine resin uptake in adult women.

AB - Objective: To investigate the effects of chronic administration of GnRH agonists (GnRH-a) on pituitary TSH and PRL secretion in adult women. Design: Prospective case-controlled study. Setting: Academic division of Reproductive Endocrinology, Department of Obstetrics and Gynecology. Patients: Ten ovulatory women and 10 women treated with monthly depot injections of leuprolide acetate (3.75 mg) were studied. Interventions: All subjects underwent pituitary stimulation with human thyrotropin-releasing hormone (TRH), 500 μg IV. Main Outcome Measures: Basal and post-TRH-stimulated serum levels of TSH and PRL at 15, 30, 45, 60, 90, 120, and 180 minutes were compared among the two groups. Also, basal of T4, triiodothyronine, and triiodothyronine resin uptake studies were obtained and compared among the GnRH-a-treated and control groups. Results: No statistically significant difference between baseline or TRH-stimulated serum TSH and PRL could be detected between control and GnRH-a-treated groups of women. Furthermore, these groups were similar with respect to routine thyroid function assays. Conclusion: Gonadotropin-releasing hormone agonist does not significantly affect baseline or TRH-stimulated TSH and PRL levels nor basal serum T4 and triiodothyronine levels or triiodothyronine resin uptake in adult women.

KW - Gonadotropin-releasing hormone agonist

KW - pituitary

KW - prolactin

KW - thyroid-stimulating hormone

UR - http://www.scopus.com/inward/record.url?scp=0029089213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029089213&partnerID=8YFLogxK

M3 - Article

C2 - 7672137

AN - SCOPUS:0029089213

VL - 64

SP - 698

EP - 702

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 4

ER -